Geoffrey Kim
About Geoffrey Kim
Geoffrey Kim is the Chief Executive Officer and Co-Founder of Pi Health, and serves as VP of Applied Innovation at BeiGene. He has extensive experience in oncology, having held senior positions at AstraZeneca, the Food and Drug Administration, and Hematology Oncology Safety Net Providers.
Current Roles at Pi Health and BeiGene
Geoffrey Kim currently serves as the Chief Executive Officer and Co-Founder of Pi Health, a hybrid company based in Maryland, United States. In addition to his role at Pi Health, he is the Vice President of Applied Innovation at BeiGene. His responsibilities encompass driving innovation in healthcare and leveraging his extensive experience in oncology to enhance strategic initiatives at both organizations.
Previous Senior Roles at AstraZeneca
From 2017 to 2019, Geoffrey Kim served as Vice President of Oncology and Head of Oncology Strategic Combinations at AstraZeneca in Gaithersburg, MD. His role involved overseeing oncology strategy and developing combination therapies, advancing the company's focus on innovative cancer treatments. This position underscored his leadership and expertise in oncology, contributing to vital advancements in cancer care.
Service at the Food and Drug Administration
Geoffrey Kim has an extensive history with the Food and Drug Administration (FDA). He served as a Medical Officer for five years from 2010 to 2015 in White Oak, MD, before being appointed as the Director of the Division of Oncology Products 1, a role he held from 2015 to 2017. During his tenure, he played a crucial role in the regulation and approval of oncology products, significantly impacting the development and accessibility of cancer treatments.
Experience in Oncology and Hematology
Geoffrey Kim's experience in oncology is both extensive and varied. He worked as an Oncologist at Hematology Oncology Safety Net Providers for six years from 2011 to 2017 in Silver Spring, MD. Additionally, he completed a fellowship at the National Cancer Institute from 2007 to 2010, where he further specialized in oncology and cancer research. His clinical and research experiences have substantially contributed to his expertise in the field.
Educational Background
Geoffrey Kim's educational foundation is solidly rooted in prestigious institutions. He earned his MD from New York Medical College, where he studied from 2000 to 2004. Prior to that, he achieved a BS from UCLA, studying from 1995 to 1999. His robust academic background underpins his extensive professional achievements and his ongoing contributions to medical science and healthcare innovation.